Management of Heart Failure

  • ID: 1367615
  • Book
  • 404 Pages
  • John Wiley and Sons Ltd
1 of 4
Management of Heart Failure offers an international perspective on current approaches to treating heart failure. This book describes recent advances in therapeutics and pharmacology, as well as ongoing clinical trials. It gives an authoritative review of available agents and their clinical applications, reports on recently completed trials, and reviews new developments and ′breaking news′ in clinical pharmacology.

The book has four major sections:

  • A review of screening, assessment and diagnosis, incorporating the latest guidelines on prevention
  • An update on drug treatments
  • An update on device therapy
  • Recommendations on best practice for managing clinically challenging cases.

An accessible reference work for hospital–based specialists, Management of Heart Failure provides physicians in cardiovascular medicine, cardiac and vascular surgery, and critical care with the key facts, for use as and when they are required. The liberal incorporation of flow charts, figures and tables organizes the available information clearly and logically to enhance its application to management strategies.

Note: Product cover images may vary from those shown
2 of 4
List of contributors.

Section 1 Prevention and evaluation of heart failure.

1 Preventing heart failure (Barry H. Greenberg, MD and Denise D. Barnard, MD).

2 Biomarkers in heart failure (Leo Slavin, MD, Thomas K. Ro, MD and Alan S. Maisel, MD, FACC).

3 Imaging the failing heart (Nico R. Van de Veire, MD, PhD and Jeroen J. Bax, MD, PhD).

Section 2 Treatment modalities.

4 Neurohormonal blocking agents in the treatment of patients with left ventricular dysfunction and heart failure (Ruchika Dutta, MD and Barry H. Greenberg, MD).

5 Digoxin, diuretics, and vasodilators in heart failure (Dawn Lombardo, MD).

6 Management of comorbidity in chronic heart failure (Justin A. Ezekowitz, MBBCh, MSc, FRCPC and Michael A. McDonald, MD, FRCPC).

7 Emerging therapies for heart failure (Barry H. Greenberg, MD and John G.F. Cleland, MD, FRCP, FESC, FACC).

Section 3 Device and anti–arrhythmic therapy of heart failure.

8 Preventing sudden cardiac arrest in the heart failure patient (Sanjiv M. Narayan, MB, MD, FRCP, FACC).

9 Cardiac resynchronization therapy: indications for treatment and strategies for optimizing results (Sanjiv M. Narayan, MB, MD, FRCP, FACC).

10 Treatment of atrial arrhythmias in heart failure patients (Mark D. O′Neill, MB, BCh, BAO, DPhil; Matthew Wright, MBBS, PhD; Pierre Ja s, MD; Sebastien Knecht, MD; Isabelle Nault, MD; Seiichiro Matsuo, MD; Shinsuke Miyazaki, MD; Andrej Pernat, MD; Amir Jadidi, MD; Frederic Sacher, MD; D. Wyn Davies, MD, FRCP, FHRS; Jacques Cl´ementy, MD; Michel Ha ssaguerre, MD and M´el`eze Hocini, MD).

11 Devices for following heart failure patients (Philip B. Adamson, MD, FACC).

Section 4 Individualizing treatment of heart failure.

12 Recognising and managing the patient with heart failure and preserved ejection fraction (Margaret M. Redfield, MD).

13 Treating systolic heart failure (Vijay U. Rao, MD, PhD and John R. Teerlink, MD, FACC, FAHA, FESC).

14 Treatment of acutely decompensated heart failure (John R. Teerlink, MD, FACC, FAHA, FESC).

15 Management of advanced heart failure (Ronald Freudenberger, MD).


Note: Product cover images may vary from those shown
3 of 4


4 of 4
Barry H. Greenberg
Denise Barnard
Sanjiv Narayan
John R. Teerlink
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown